EMBALL’ISO, a manufacturer of high-performance thermal packaging based in Saint-Georges-de-Reneins (Auvergne-Rhône-Alpes, France), relies on a global network of 12 production sites, 15 service centers, and collection points in 80 countries to guarantee its pharmaceutical clients a reliable, responsive, and sustainable cold chain, wherever they are located.
In an industry where a temperature breach can compromise a batch of vaccines, an oncology treatment, or a biological sample, logistical resilience is no longer optional it is a regulatory and operational requirement. Since 1990, EMBALL’ISO has built its model around a simple principle: combining strong local roots with global operating capacity.
A model born of family independence
Founded in 1990 by Pierre Casoli, a chemical engineer and the company’s current Chairman, EMBALL’ISO is one of the few family-owned and independent companies specializing in the pharmaceutical cold chain. This independence allows the company to make long-term decisions and offer its industrial partners stability and continuity.
Today, 220 employees work toward this mission, with headquarters still located at the heart of the Auvergne-Rhône-Alpes region the company’s historic site, rebuilt in 2009 to strict environmental standards, notably using geothermal energy.
An international expansion designed for customer proximity
EMBALL’ISO’s history is one of gradual, carefully managed internationalization:
- 1990: The company is founded in France.
- 1992–2005: First international operations open in Germany, the United Kingdom, China, and Singapore.
- 2009: The French headquarters is rebuilt to demanding environmental standards.
- 2014–2022: Global acceleration with new sites in the United States, Brazil, India, Mexico, Ireland, and Switzerland.
- 2024: Network reinforcement in Australia, South Korea, and Vietnam.
This trajectory was not driven by opportunism, but by the will to follow the real needs of pharmaceutical industries and clinical logistics specialists, wherever they operate. The network today covers North and South America, Europe, Asia-Pacific, and the Middle East, through production subsidiaries, commercial entities, and dedicated service centers from Paris to Shanghai, San Francisco to Dubai, and through Copenhagen, Seoul, Marburg, Casablanca, Toronto, and Melbourne.
The numbers
The strength of a logistics network is measured by its ability to absorb demand spikes without breaking the chain. EMBALL’ISO relies on:
- 12 production sites across 4 continents;
- 15 service and storage centers;
- active collection points in 80 countries for packaging reuse;
- ISO 9001 certification, guaranteeing consistent quality processes across the group.
This architecture was put to the test on a real-world scale during the global distribution of Covid-19 vaccines. EMBALL’ISO demonstrated rapid scalability, opening and operating dedicated production sites on an emergency basis, in close coordination with its pharmaceutical clients, to meet unprecedented global demand.
A global network in the service of sustainability
For EMBALL’ISO, resilience and sustainability go hand in hand. The company was a pioneer in promoting the reuse of thermal packaging, a circular-economy model that allows its clients to cut CO₂ emissions by 93% compared to single-use packaging. This reuse model relies directly on the density of the 80-country collection network: the denser the local network, the more efficient the reuse cycle globally.
This commitment is recognized through an EcoVadis Gold medal, an SBTi (Science Based Targets initiative) commitment, and the regular publication of a CSR report detailing the company’s full carbon footprint. EMBALL’ISO also benefits from the support of the Auvergne-Rhône-Alpes Region, as part of its “Ambition Industrie du Futur” initiative, as well as from BPI France two marks of institutional trust that support the group’s growth.
Why local proximity remains strategic
A global network only has value if it can still respond locally, within short lead times, with a detailed understanding of each market’s regulations and constraints.
This subsidiary-based organization allows EMBALL’ISO to cover the full range of pharmaceutical cold chain needs from clinical trials to the last mile with the same standard of quality, wherever the client is located.
In summary
The efficiency of a global cold chain rests on solid foundations, built over time. With 35 years of expertise, independent family ownership, 12 production sites, 15 service centers, and a collection network spanning 80 countries, EMBALL’ISO proves that it is possible to combine local proximity with international reach in service of the healthcare industries.
To find the EMBALL’ISO contact closest to your site, visit our [Our Locations] page
To learn more about our solutions dedicated to pharmaceutical industries, visit our [Fields of Application] page
Frequently Asked Questions
- Since when has EMBALL'ISO operated internationally ? EMBALL'ISO began its international expansion between 1992 and 2005, opening operations in Germany, the United Kingdom, China, and Singapore, before accelerating sharply between 2014 and 2024.
- How many sites does EMBALL'ISO have worldwide ? There are 12 production sites across 4 continents and 15 service and storage centers, complemented by collection points in 80 countries for packaging reuse.
- Is EMBALL'ISO an independent company? Yes. Founded in 1990 by Pierre Casoli, still the group's Chairman, EMBALL'ISO remains a family-owned, independent company, which allows it to pursue a long-term strategy.
- What is the environmental impact of EMBALL'ISO's reuse model? Reusing thermal packaging enables a 93% reduction in CO₂ emissions compared to single-use packaging.